BR0012192A - Derivado de ácido quinolinocarboxìlico ou seus sais - Google Patents

Derivado de ácido quinolinocarboxìlico ou seus sais

Info

Publication number
BR0012192A
BR0012192A BR0012192-4A BR0012192A BR0012192A BR 0012192 A BR0012192 A BR 0012192A BR 0012192 A BR0012192 A BR 0012192A BR 0012192 A BR0012192 A BR 0012192A
Authority
BR
Brazil
Prior art keywords
salts
derived
extremely high
quinolinocarboxylic
quinolinocarboxylic acid
Prior art date
Application number
BR0012192-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Akira Yazaki
Yoshiko Niino
Yasuhiro Kuramoto
Yuzo Hirao
Yoshihiro Ohshita
Norihiro Hayashi
Hirotaka Amano
Original Assignee
Wakunaga Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharma Co Ltd filed Critical Wakunaga Pharma Co Ltd
Publication of BR0012192A publication Critical patent/BR0012192A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR0012192-4A 1999-07-01 2000-06-22 Derivado de ácido quinolinocarboxìlico ou seus sais BR0012192A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18749299 1999-07-01
PCT/JP2000/004096 WO2001002390A1 (fr) 1999-07-01 2000-06-22 Derive d'acide quinolinecarboxylique et ses sels

Publications (1)

Publication Number Publication Date
BR0012192A true BR0012192A (pt) 2002-06-18

Family

ID=16207019

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012192-4A BR0012192A (pt) 1999-07-01 2000-06-22 Derivado de ácido quinolinocarboxìlico ou seus sais

Country Status (25)

Country Link
US (1) US6858625B1 (es)
EP (1) EP1193266B1 (es)
JP (1) JP3477465B2 (es)
KR (1) KR100628414B1 (es)
CN (1) CN1157389C (es)
AT (1) ATE248162T1 (es)
AU (1) AU766014B2 (es)
BR (1) BR0012192A (es)
CA (1) CA2376760C (es)
CZ (1) CZ302033B6 (es)
DE (1) DE60004846T2 (es)
DK (1) DK1193266T3 (es)
ES (1) ES2206257T3 (es)
HK (1) HK1047103B (es)
HU (1) HUP0201549A3 (es)
IL (2) IL147043A0 (es)
MX (1) MXPA02000103A (es)
NO (1) NO321803B1 (es)
NZ (1) NZ516201A (es)
PT (1) PT1193266E (es)
RU (1) RU2236408C2 (es)
SK (1) SK285814B6 (es)
TW (1) TW576832B (es)
WO (1) WO2001002390A1 (es)
ZA (1) ZA200110357B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3477466B2 (ja) 1999-09-02 2003-12-10 湧永製薬株式会社 キノリンカルボン酸誘導体又はその塩
US7172535B2 (en) * 2004-10-28 2007-02-06 Volmar John F Upper back exercise machine and method of use
WO2006054623A1 (ja) 2004-11-17 2006-05-26 Wakunaga Pharmaceutical Co., Ltd. 新規ピリドンカルボン酸誘導体又はその塩
KR20110091504A (ko) * 2008-09-24 2011-08-11 립-엑스 파마슈티칼즈, 인크. 퀴놀론 화합물의 제조 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO177302C (no) 1989-03-16 1995-08-23 Esteve Labor Dr Analogifremgangsmåte til fremstilling av terapeutisk aktive substituerte azetidinylkinolon(naftyridon)karboksylsyrederivater
CA2168764C (en) 1993-08-13 2000-01-18 Sung June Yoon Novel quinolone carboxylic acid derivatives
CN1105715C (zh) * 1995-09-22 2003-04-16 涌永制药株式会社 新型吡啶酮羧酸衍生物或其盐以及以它们为有效成分的抗菌剂
PT897919E (pt) 1996-04-19 2004-11-30 Wakunaga Pharma Co Ltd Novos derivados do acido piridonacarboxilico ou seus sais e agentes anti-bacterianos contendo-os como ingrediente activo
KR100516379B1 (ko) 1996-11-28 2005-09-26 와쿠나가 세이야쿠 가부시키 가이샤 신규 피리돈카르복실산 유도체 또는 그의 염 및 이를 유효 성분으로 하는 의약
DE19652239A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
JPH11292873A (ja) 1998-04-07 1999-10-26 Dainippon Pharmaceut Co Ltd キノロンカルボン酸誘導体の製造方法およびその中間体

Also Published As

Publication number Publication date
IL147043A0 (en) 2002-08-14
SK285814B6 (sk) 2007-08-02
SK19162001A3 (sk) 2002-06-04
NO321803B1 (no) 2006-07-03
IL147043A (en) 2007-07-04
ZA200110357B (en) 2002-12-18
EP1193266A4 (en) 2002-08-14
DK1193266T3 (da) 2003-11-24
EP1193266A1 (en) 2002-04-03
TW576832B (en) 2004-02-21
MXPA02000103A (es) 2003-07-21
RU2236408C2 (ru) 2004-09-20
CN1157389C (zh) 2004-07-14
CA2376760C (en) 2008-11-25
US6858625B1 (en) 2005-02-22
DE60004846T2 (de) 2004-06-03
NO20016378D0 (no) 2001-12-27
WO2001002390A1 (fr) 2001-01-11
CN1358183A (zh) 2002-07-10
ATE248162T1 (de) 2003-09-15
CA2376760A1 (en) 2001-01-11
JP3477465B2 (ja) 2003-12-10
KR100628414B1 (ko) 2006-09-26
HUP0201549A2 (en) 2002-08-28
PT1193266E (pt) 2003-12-31
KR20020020733A (ko) 2002-03-15
NO20016378L (no) 2002-02-28
EP1193266B1 (en) 2003-08-27
ES2206257T3 (es) 2004-05-16
AU5567900A (en) 2001-01-22
CZ20014598A3 (cs) 2002-05-15
CZ302033B6 (cs) 2010-09-08
DE60004846D1 (de) 2003-10-02
NZ516201A (en) 2003-06-30
AU766014B2 (en) 2003-10-09
HK1047103B (zh) 2005-04-08
HK1047103A1 (en) 2003-02-07
HUP0201549A3 (en) 2003-11-28

Similar Documents

Publication Publication Date Title
ES2096215T3 (es) Tucaresol como agente inmunopotenciador.
BR0011116A (pt) Usos de uma nsaid que libera no como um sal farmaceuticamente aceitável ou um enanciÈmero do mesmo, e de uma nsaid que libera no e de um inibidor de bomba de próton suscetìvel a ácido ou um sal do mesmo ou um enanciÈmero ou de um sal do enanciÈmero, método para o tratamento de uma infecção bacteriana, e, formulação farmacêutica adequada para uso no tratamento de infecções bacterianas
BR0013010A (pt) Formulação de cloreto de sódio de moxifloxacina
NO20063105L (no) Anordning og fremgangsmate for administrering av terapeutiske midler
BR0309083A (pt) Compostos derivados de benzoxazinona, sua preparação e uso como medicamentos
HUP0202749A2 (hu) Levoszimendánt tartalmazó oldat formájú gyógyszerkészítmény
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
BR0015177A (pt) ésteres de ácido benzóico de oxazolidinonas possuindo um substituinte hidroxiacetilpiperazina
BR0012192A (pt) Derivado de ácido quinolinocarboxìlico ou seus sais
BRPI0317188A2 (pt) Novo derivado de 2,4-diamino-1,3,5-triazina
BR9915671A (pt) Compostos de organofósforo e uso dos mesmos
BR9913990A (pt) Uso de compostos organofosforados para a produção de preparações farmacêuticas para o tratamento terapêutico e profilático de infecções ou como um fungicida, bactericida ou herbicida em plantas
BR9915639A (pt) Uso de derivados de ácido fosfonofórmico para o tratamento de infecções
BR0009135A (pt) Derivado de benzamida e medicamento que ocontém
DK93091A (da) Laegemidler til behandling af toxoplasmose
NO993911D0 (no) Remedier/Forebygningsmidler for åndedrettssykdommer
BR9908452A (pt) Composição fungicida que compreende uma benzoilfeniluréia
BRPI0414223A (pt) uso de extratos de gentiana lutea como um agente antimicrobiano
BR0307039A (pt) Compostos, em particular de derivados uréias ou ésteres do ácido haloacetamidobenzóico e sua utilização para o tratamento de doenças parasitárias
NO20013464L (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
DE60214578D1 (de) Polymaleinimid-verbindungen und ihre medizinische verwendung
UA31078A (uk) Інгібітор вірусу імунодефіциту людини ( даримід )
BR9206978A (pt) Composição farmacêutica para inibir infecção com vírus da aids
EA200100768A1 (ru) Применение 3-изоксазолидинонов и гидроксиаминокислот для лечения инфекций
TH15420A (th) สารประกอบไทรแอซีนที่ใช้ในการรักษาและการใช้ประโยชน์

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10 (VIII), 11 E 13 DA LPI

B09T Decision of refusal: decision cancelled [chapter 9.2.1 patent gazette]

Free format text: REFERENTE A RPI 2039 DE 02/02/2010.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13, 24 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.